PGI2 Antibodies

Santa Cruz Biotechnology features a diverse variety of PGI2 monoclonal antibodies for investigating prostaglandin I2 (PGI2) in various biological processes. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Prostaglandin I2, also known as prostacyclin, is a potent vasodilator and inhibitor of platelet aggregation, playing a crucial role in cardiovascular health. PGI2 is involved in regulating blood flow and maintaining vascular homeostasis, making it an important target for research in cardiovascular diseases and other related conditions. Understanding PGI2 function can provide insights into therapeutic strategies for managing hypertension and atherosclerosis. Research focused on PGI2 continues to reveal new pathways and mechanisms in cardiovascular biology. Investigating PGI2 signaling pathways helps advance knowledge in vascular medicine and therapeutic development. Santa CruzBiotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cardiovascular health and disease.